Though no longer as cutting-edge as it once was, the S-400 remains an effective air defense system—and has caused no shortage ...

VANCOUVER, British Columbia, Dec. 16, 2020 (GLOBE NEWSWIRE) -- TRIUMF, Canada’s particle accelerator centre, today announced it has entered into a collaboration agreement with Fusion Pharmaceuticals ...

CHALK RIVER, Ontario and VANCOUVER, British Columbia, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Canadian Nuclear Laboratories (CNL), Canada’s premier nuclear science and technology laboratory, and TRIUMF, ...

Art is colliding with science inside Canada's home for particle and nuclear physics. The artist-in-residence program at TRIUMF in Vancouver is bridging the divide between the two disciplines, allowing ...

New TRIUMF research from the Saint Mary’s University-led IRIS group has unveiled an unexpected shape deformation in the nucleus of helium-8 (He 8), providing further insight into the unique dynamics ...

Stock Score Locked: Want to See it? Benzinga Rankings give you vital metrics on any stock – anytime.

On September 25-26, 2014, TRIUMF and Advanced Applied Physics Solutions, Inc. Innovation and Education – Minister of State for Science and Technology Ed Holder (left) visited TRIUMF in September to ...

We are the private sector-facing part of TRIUMF. If you are a company or a private investor wanting to interact with TRIUMF in any way, we are here to help facilitate that. Originally, our focus was ...

A picture shows two Russian S-400 Triumf S-400 Triumf missile system at the Russian Hmeimim military base in Latakia province, in the northwest of Syria, on December 16, 2015. Russia began its air war ...

India has concluded price negotiations with Russia for a nearly Rs 40,000 crore deal to procure S-400 Triumf air defence missile systems for the Indian Air Force, officials said. They said the two ...

Designed to maximize impact, build on existing strengths, and capitalize on emerging opportunities, TRIUMF's Five-Year Plan 2020-2025 lays out a vision for Canada's particle accelerator center for the ...

TRIUMF, Canada's particle accelerator center, today announced it has entered into a collaboration agreement with Fusion Pharmaceuticals Inc. (Nasdaq: FUSN), a clinical-stage oncology company focused ...